Terminalcare Support Institute, Inc. (7362) AI Stock Analysis

• Market Cap: ¥1.27B
• Dividend Yield: N/A
• Average Volume (3M): 1.44K
• Price to Earnings (P/E): 15.1
• Beta (1Y): 0.30
• Revenue Growth: 9.76%
• EPS Growth: -10.10%
• Country: JP
• Employees: 451
• Sector: Healthcare
• Sector Strength: 51
• Industry: Medical - Care Facilities
• EPS (TTM): 11.46
• Shares Outstanding: 1,533,100
• 10 Day Avg. Volume: 1,300
• 30 Day Avg. Volume: 1,443
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥907.00
• Price Target Upside: 8.49% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 67 Neutral
• Price Target: ¥907.00 ▲(8.49% Upside)

The company's solid financial performance, characterized by revenue growth and stable gross margins, is a key strength. However, challenges in profitability and rising debt levels are concerns. Technical indicators suggest a neutral to slightly bullish outlook, while valuation appears reasonable. The absence of earnings call data and corporate events limits additional insights.

Terminalcare Support Institute, Inc. Business Overview & Revenue Model

Company Description

Terminalcare Support Institute, Inc. (7362) is a leading provider of comprehensive support services aimed at enhancing the quality of life for individuals facing terminal illnesses. Operating primarily in the healthcare sector, the company specializes in palliative care, hospice services, and educational resources for both patients and caregivers. With a mission to deliver compassionate care and support, Terminalcare focuses on empowering families through innovative programs and personalized services tailored to meet the unique needs of those at the end of life.

How the Company Makes Money

Terminalcare Support Institute, Inc. generates revenue through multiple streams, primarily by offering paid services in palliative and hospice care. The company charges for its various care packages, which include in-home support, nursing services, and counseling for patients and their families. Additionally, Terminalcare partners with healthcare providers and insurance companies to receive reimbursements for services rendered, significantly contributing to its revenue. Educational programs and workshops for healthcare professionals and caregivers also serve as a secondary revenue stream, further solidifying its financial position in the healthcare landscape.

Terminalcare Support Institute, Inc. Financial Statement Overview

Summary

Terminalcare Support Institute, Inc. shows a solid growth trajectory with increasing revenues and stable gross margins. However, the decline in net profit margins and return on equity suggests challenges in maintaining profitability. The balance sheet is robust, but rising debt levels warrant caution. Cash flow management, particularly regarding capital expenditures, is crucial for sustaining financial health.

Income Statement

The company has demonstrated consistent revenue growth over the years, with a notable increase from 2023 to 2024. Gross profit margins have remained stable, indicating effective cost management. However, net profit margins have slightly decreased, which may suggest rising expenses or other cost pressures. EBIT and EBITDA margins show operational efficiency, but there is room for improvement in profitability.

Balance Sheet

The balance sheet reflects a moderate debt-to-equity ratio, indicating a balanced approach to leverage. The equity ratio is healthy, suggesting a strong asset base relative to liabilities. However, the increase in total debt over the years could pose a risk if not managed carefully. Return on equity has decreased, highlighting a need for improved profitability to enhance shareholder returns.

Cash Flow

Operating cash flow has been positive, supporting the company's operational needs. However, free cash flow has been negative in recent years due to high capital expenditures, which could limit financial flexibility. The operating cash flow to net income ratio is strong, indicating efficient cash generation from operations. The company needs to manage its capital expenditures to improve free cash flow.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	4.74B	4.71B	4.25B	4.10B	3.40B	2.93B
Gross Profit	658.32M	664.67M	646.76M	685.84M	599.50M	464.84M
EBITDA	272.07M	321.42M	300.83M	334.75M	284.93M	237.34M
Net Income	89.21M	113.77M	126.67M	157.54M	138.03M	102.29M
Balance Sheet
Total Assets	5.11B	4.80B	4.09B	3.03B	2.88B	2.06B
Cash, Cash Equivalents and Short-Term Investments	1.08B	1.13B	1.38B	1.09B	874.72M	411.85M
Total Debt	3.12B	2.81B	2.26B	1.34B	1.43B	1.44B
Total Liabilities	3.81B	3.49B	2.90B	1.95B	1.95B	1.82B
Stockholders Equity	1.30B	1.31B	1.19B	1.08B	927.37M	237.34M
Cash Flow
Free Cash Flow	0.00	-797.40M	-597.43M	303.05M	-57.27M	51.51M
Operating Cash Flow	0.00	304.51M	238.18M	812.73M	462.19M	124.89M
Investing Cash Flow	0.00	-1.10B	-836.33M	-510.68M	-523.54M	-74.58M
Financing Cash Flow	0.00	545.64M	892.46M	-90.11M	523.02M	-56.64M

Terminalcare Support Institute, Inc. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 836.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7362, the sentiment is Positive. The current price of 836 is below the 20-day moving average (MA) of 837.95, above the 50-day MA of 830.90, and below the 200-day MA of 844.68, indicating a neutral trend. The MACD of 0.38 indicates Positive momentum. The RSI at 51.30 is Neutral, neither overbought nor oversold. The STOCH value of 31.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7362.

Terminalcare Support Institute, Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9220	78 Outperform	¥2.89B	7.13		2.82%	5.37%	-9.33%
2425	77 Outperform	¥3.07B	9.55		2.47%	-0.34%	-21.06%
7129	75 Outperform	¥3.20B	10.96		2.62%	4.76%	134.83%
7133	71 Outperform	¥9.39B	13.35		1.51%	18.30%	37.13%
7362	67 Neutral	¥1.27B	15.09		―	9.76%	-10.10%
7061	66 Neutral	¥11.12B	20.61		1.14%	20.37%	-5.97%
Sector *	51 Neutral	$7.93B	-0.32	-43.43%	2.21%	22.30%	-1.88%